10X Genomics Q2 Revenue USD 151 Million Vs. IBES Estimate USD 146.8 Million
TXG•Q2 revenue and profitability
Aug. 6 (Reuters) - 10X Genomics Q2 operating income was USD -19.6 million.
- Q2 net income was USD -17.9 million
- Q2 gross margin was 74%
- FY revenue outlook was USD 610-630 million vs. IBES estimate of USD 613.9 million




